Harvey Rubin of the Perelman School of Medicine and Joshua Plotkin of the School of Arts and Sciences and the School of Engineering and Applied Science discussevolution through viruses.
PHILADELPHIA -- Researchers from the Perelman School of Medicine at the University of Pennsylvania are in the midst of testing a personalized, dendritic cell vaccine in patients with recurrent ovarian, primary peritoneal or fallopian tube cancer – a group of patients who typically have few treatment options.
Arthur Caplan of the Perelman School of Medicine shares his views on an AIDS discovery.
Jeremy Siegel of the Wharton School discusses stock market strategy.
Harvey Rubin and Arthur Caplan of the Perelman School of Medicine comment on lab-altered bird flu.